SCIENTURE HOLDINGS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period
SCIENTURE HOLDINGS, INC. (SCNX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period of 12.30 thousand shares for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-30.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod · last filed 2020-03-30
- SCIENTURE HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2019-12-31 was -23.40K shares.
- SCIENTURE HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2019 was 12.30K shares.
- SCIENTURE HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2017 was 75.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month |
|---|---|---|---|
| 2019-12-31 | -23.40K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | 12.30K shares 10-K · filed 2020-03-30 | |
| 2019-09-30 | 35.70K shares 10-Q · filed 2019-10-28 | ||
| 2017-12-31 | 75.00K shares 10-K · filed 2019-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |